A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer
Clinical trial NCT03872791 · COMPLETED
Trial details
- NCT number
- NCT03872791
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2022-08-16
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.